Elation Health Just Acquired a Voice AI Startup. The Goal Is an EHR That Does the Admin Work.
Most EHR companies buy other EHR companies. Elation Health’s second acquisition went somewhere different.
On June 2, Elation announced it acquired Aster, a two-year-old AI startup that built Atlas: a voice agent for healthcare practices that handles front-office work. Scheduling calls, patient intake, administrative follow-up. Elation’s stated destination is an “agentic operating system for primary care,” software that acts on a clinician’s behalf rather than just assisting.
What Aster Built
Aster launched in 2023 out of Y Combinator. The founders are two sisters: Fifi Kara, a former Meta design lead, and Dr. Lailah Kara-Newton, an OB/GYN who built the company from a specific personal experience.
Dr. Kara-Newton had undiagnosed preeclampsia during her first pregnancy. The outcome was an emergency C-section and a NICU stay for her son. She founded Aster to build technology that catches problems and handles things before a clinician or patient has to deal with consequences. The product they shipped was Atlas, a voice agent for medical practice front offices: handling scheduling calls, new patient intake and administrative follow-up by phone.
Aster raised $2.8 million from Zeal Capital Partners, Cornerstone Ventures and Octopus Ventures. This is Elation’s second acquisition, following its purchase of Lightning MD in 2023.
Why DPC Practices Should Pay Attention
Elation CEO Kyna Fong was specific about what she’s building. The Aster deal accelerates a vision she’s described as an agentic operating system for primary care: AI that takes actions, not just surfaces information.
For a standard clinic with front-desk staff, that framing lands as a productivity tool. For a solo DPC practice running with one physician and minimal support, it’s a different kind of conversation.
DPC physicians often absorb the front-office work themselves. New member inquiries, scheduling changes, lab calls, refill requests, the occasional phone tag that eats thirty minutes. That’s not clinical work, but it competes directly with patient time. If voice AI can handle a meaningful share of inbound phone traffic, the time savings at a solo practice are proportionally much larger than at a ten-person operation.
Elation currently serves more than 50,000 clinical users and 24 million patients. Many DPC practices pair it with Hint Health for billing and Spruce for messaging. The three-app stack covers most of what a practice needs, but it requires context-switching and the pieces don’t connect cleanly. A voice agent that handles phone-based administrative work inside Elation starts to make that stack look different, and potentially more capable at the tasks many practices find most burdensome.
What This Means
If you’re already on Elation, this acquisition doesn’t change your workflow this week. The Aster team just joined, and building AI agents that work reliably in clinical settings takes longer than a press release cycle.
What it does reveal is where Elation is pointing. Two acquisitions in three years, both targeting specific operational gaps: billing infrastructure with Lightning MD, front-office automation with Aster. The picture forming is less “we added an AI feature” and more “we’re building a complete operating layer for independent primary care practices.”
For physicians still evaluating platforms, the competitive pace is worth watching. Aster raised funding, shipped a voice product and got acquired in under three years. In April, Ultralight raised $9.3 million to build an AI-native primary care EHR from scratch. The DPC software market moving into 2027 will look different from what it looks like today.
The practices that gain the most from that shift will probably be solo physicians who apply time savings directly: an hour less on the phone each day is an hour more with patients, or an hour earlier out of the office. If Elation’s Atlas integration delivers on the agentic framing, that kind of quiet operational change is what it would look like in practice.
The bet is on the table. Whether it pays out is a question for next year.